U.S. markets open in 5 hours 4 minutes

MediPharm Labs Corp. (MEDIF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3572-0.0128 (-3.46%)
At close: 3:57PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/10/2021
Current
12/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
93.36M64.65M91.77M114.74M151.04M
Enterprise Value 3
92.16M60.68M83.06M106.61M131.27M
Trailing P/E
191.03N/AN/AN/A158.84
Forward P/E 1
N/AN/AN/AN/A14.99
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
1.751.221.121.311.65
Price/Book (mrq)
1.490.771.051.331.63
Enterprise Value/Revenue 3
2.5610.0216.797.6611.84
Enterprise Value/EBITDA 7
-1.73-3.19-7.08-53.20-6.35

Trading Information

Stock Price History

Beta (5Y Monthly) 0.71
52-Week Change 3-10.84%
S&P500 52-Week Change 347.47%
52 Week High 30.7850
52 Week Low 30.3530
50-Day Moving Average 30.3782
200-Day Moving Average 30.4622

Share Statistics

Avg Vol (3 month) 3809.09k
Avg Vol (10 day) 3344.3k
Shares Outstanding 5257.95M
Implied Shares Outstanding 6N/A
Float 237.95M
% Held by Insiders 18.08%
% Held by Institutions 110.95%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Oct 03, 2018
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin -184.25%
Operating Margin (ttm)-195.25%

Management Effectiveness

Return on Assets (ttm)-30.62%
Return on Equity (ttm)-64.02%

Income Statement

Revenue (ttm)36.01M
Revenue Per Share (ttm)0.26
Quarterly Revenue Growth (yoy)-81.30%
Gross Profit (ttm)-44.42M
EBITDA -59.93M
Net Income Avi to Common (ttm)-66.35M
Diluted EPS (ttm)-0.3950
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)21.97M
Total Cash Per Share (mrq)0.09
Total Debt (mrq)18.46M
Total Debt/Equity (mrq)23.54
Current Ratio (mrq)3.36
Book Value Per Share (mrq)0.50

Cash Flow Statement

Operating Cash Flow (ttm)-37.77M
Levered Free Cash Flow (ttm)-32.52M